These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23651333)

  • 1. The effects of ErhBMP-2-/EGCG-coated BCP bone substitute on dehiscence around dental implants in dogs.
    Shin YS; Seo JY; Oh SH; Kim JH; Kim ST; Park YB; Moon HS
    Oral Dis; 2014 Apr; 20(3):281-7. PubMed ID: 23651333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone formation of middle ear cavity using biphasic calcium phosphate lyophilized with Escherichia coli-derived recombinant human bone morphogenetic protein 2 using animal model.
    Kim SE; Yun YP; Song HR; Choi KH; Kim BH; Lee EK; Song JJ
    Int J Pediatr Otorhinolaryngol; 2013 Sep; 77(9):1430-3. PubMed ID: 23830037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of biphasic calcium phosphate bone substitute on circumferential bone defects around dental implants in dogs.
    Kim S; Jung UW; Lee YK; Choi SH
    Int J Oral Maxillofac Implants; 2011; 26(2):265-73. PubMed ID: 21483879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alveolar ridge augmentation using anodized implants coated with Escherichia coli-derived recombinant human bone morphogenetic protein 2.
    Huh JB; Park CK; Kim SE; Shim KM; Choi KH; Kim SJ; Shim JS; Shin SW
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):42-9. PubMed ID: 21194992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone formation of block and particulated biphasic calcium phosphate lyophilized with Escherichia coli-derived recombinant human bone morphogenetic protein 2 in rat calvarial defects.
    Kim JW; Choi KH; Yun JH; Jung UW; Kim CS; Choi SH; Cho KS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Sep; 112(3):298-306. PubMed ID: 21292513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of guided bone regeneration around commercially pure titanium and hydroxyapatite-coated dental implants. II. Histologic analysis.
    Stentz WC; Mealey BL; Gunsolley JC; Waldrop TC
    J Periodontol; 1997 Oct; 68(10):933-49. PubMed ID: 9358360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guided bone regeneration using cyanoacrylate-combined calcium phosphate in a dehiscence defect: a histologic study in dogs.
    Lee JS; Ko SH; Kim YT; Jung UW; Choi SH
    J Oral Maxillofac Surg; 2012 Sep; 70(9):2070-9. PubMed ID: 22749520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of the osteogenic potential of ErhBMP-2-/EGCG-coated biphasic calcium phosphate bone substitute:
    Hwang JH; Oh S; Kim S
    J Periodontal Implant Sci; 2019 Apr; 49(2):114-126. PubMed ID: 31098332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of bone morphogenetic protein and proportion of hydroxyapatite on new bone formation in biphasic calcium phosphate graft: two pilot studies in animal bony defect model.
    Yun PY; Kim YK; Jeong KI; Park JC; Choi YJ
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1909-17. PubMed ID: 25443868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-rich plasma may not provide any additional effect when associated with guided bone regeneration around dental implants in dogs.
    de Vasconcelos Gurgel BC; Gonçalves PF; Pimentel SP; Ambrosano GM; Nociti Júnior FH; Sallum EA; Casati MZ
    Clin Oral Implants Res; 2007 Oct; 18(5):649-54. PubMed ID: 17877464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone formation and remodeling of three different dental implant surfaces with Escherichia coli-derived recombinant human bone morphogenetic protein 2 in a rabbit model.
    Lee JK; Cho LR; Um HS; Chang BS; Cho KS
    Int J Oral Maxillofac Implants; 2013; 28(2):424-30. PubMed ID: 23527344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
    Wikesjö UM; Qahash M; Polimeni G; Susin C; Shanaman RH; Rohrer MD; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):1001-10. PubMed ID: 18976397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of recombinant human growth/differentiation factor-5 (rhGDF-5) on bone regeneration around titanium dental implants in barrier membrane-protected defects: a pilot study in the mandible of beagle dogs.
    Weng D; Poehling S; Pippig S; Bell M; Richter EJ; Zuhr O; Hürzeler MB
    Int J Oral Maxillofac Implants; 2009; 24(1):31-7. PubMed ID: 19344022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone response to the multilayer BMP-2 gene coated porous titanium implant surface.
    Jiang QH; Liu L; Peel S; Yang GL; Zhao SF; He FM
    Clin Oral Implants Res; 2013 Aug; 24(8):853-61. PubMed ID: 22168601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anodized implants coated with Escherichia coli-derived rhBMP-2 in beagle dogs.
    Huh JB; Kim SE; Kim HE; Kang SS; Choi KH; Jeong CM; Lee JY; Shin SW
    Int J Oral Maxillofac Surg; 2012 Dec; 41(12):1577-84. PubMed ID: 22575178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological comparison of early wound healing following dense hydroxyapatite granule grafting and barrier placement in surgically-created bone defects neighboring implants.
    Takeshita F; Ayukawa Y; Iyama S; Suetsugu T; Oishi M
    J Periodontol; 1997 Oct; 68(10):924-32. PubMed ID: 9358359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of implants coated with rhBMP-2 using two different coating strategies: a critical-size supraalveolar peri-implant defect study in dogs.
    Lee J; Decker JF; Polimeni G; Cortella CA; Rohrer MD; Wozney JM; Hall J; Susin C; Wikesjö UM
    J Clin Periodontol; 2010 Jun; 37(6):582-90. PubMed ID: 20345393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enamel matrix derivative and bone healing after guided bone regeneration in dehiscence-type defects around implants. A histomorphometric study in dogs.
    Casati MZ; Sallum EA; Nociti FH; Caffesse RG; Sallum AW
    J Periodontol; 2002 Jul; 73(7):789-96. PubMed ID: 12146539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration.
    Ramazanoglu M; Lutz R; Ergun C; von Wilmowsky C; Nkenke E; Schlegel KA
    Clin Oral Implants Res; 2011 Dec; 22(12):1433-9. PubMed ID: 21418332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alveolar bone formation at dental implant dehiscence defects following guided bone regeneration and xenogeneic freeze-dried demineralized bone matrix.
    Cho KS; Choi SH; Han KH; Chai JK; Wikesjö UM; Kim CK
    Clin Oral Implants Res; 1998 Dec; 9(6):419-28. PubMed ID: 11429943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.